162 related articles for article (PubMed ID: 32467352)
1. Pharmacological Properties of
Dripps IJ; Chen R; Shafer AM; Livingston KE; Disney A; Husbands SM; Traynor JR; Rice KC; Jutkiewicz EM
J Pharmacol Exp Ther; 2020 Aug; 374(2):319-330. PubMed ID: 32467352
[TBL] [Abstract][Full Text] [Related]
2. Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.
Dripps IJ; Boyer BT; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Br J Pharmacol; 2018 Mar; 175(6):891-901. PubMed ID: 29278419
[TBL] [Abstract][Full Text] [Related]
3. The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.
Dripps IJ; Wang Q; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Psychopharmacology (Berl); 2017 Jan; 234(1):29-39. PubMed ID: 27624599
[TBL] [Abstract][Full Text] [Related]
4. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
5. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.
Nozaki C; Nagase H; Nemoto T; Matifas A; Kieffer BL; Gaveriaux-Ruff C
Br J Pharmacol; 2014 Dec; 171(23):5376-86. PubMed ID: 25048778
[TBL] [Abstract][Full Text] [Related]
6. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
Jutkiewicz EM; Rice KC; Traynor JR; Woods JH
Psychopharmacology (Berl); 2005 Nov; 182(4):588-96. PubMed ID: 16163520
[TBL] [Abstract][Full Text] [Related]
7. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
Psychopharmacology (Berl); 2002 Oct; 164(1):42-8. PubMed ID: 12373418
[TBL] [Abstract][Full Text] [Related]
8. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
[TBL] [Abstract][Full Text] [Related]
9. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.
Vicente-Sanchez A; Dripps IJ; Tipton AF; Akbari H; Akbari A; Jutkiewicz EM; Pradhan AA
Br J Pharmacol; 2018 Jul; 175(14):3050-3059. PubMed ID: 29722902
[TBL] [Abstract][Full Text] [Related]
11. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
[TBL] [Abstract][Full Text] [Related]
12. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
13. A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice.
Sakamoto K; Yamada D; Yamanaka N; Nishida M; Iio K; Nagase H; Saitoh A
Brain Res; 2021 Apr; 1757():147297. PubMed ID: 33516811
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
16. Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.
Perrine SA; Hoshaw BA; Unterwald EM
Br J Pharmacol; 2006 Apr; 147(8):864-72. PubMed ID: 16491101
[TBL] [Abstract][Full Text] [Related]
17. Agonist-specific down-regulation of the human delta-opioid receptor.
Okura T; Varga EV; Hosohata Y; Navratilova E; Cowell SM; Rice K; Nagase H; Hruby VJ; Roeske WR; Yamamura HI
Eur J Pharmacol; 2003 Jan; 459(1):9-16. PubMed ID: 12505529
[TBL] [Abstract][Full Text] [Related]
18. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
Jutkiewicz EM; Eller EB; Folk JE; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2004 Apr; 309(1):173-81. PubMed ID: 14722329
[TBL] [Abstract][Full Text] [Related]
19. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents.
Saitoh A; Kimura Y; Suzuki T; Kawai K; Nagase H; Kamei J
J Pharmacol Sci; 2004 Jul; 95(3):374-80. PubMed ID: 15272214
[TBL] [Abstract][Full Text] [Related]
20. The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.
Bosse KE; Jutkiewicz EM; Gnegy ME; Traynor JR
Neuropharmacology; 2008 Oct; 55(5):755-62. PubMed ID: 18602932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
